UFP Technologies Inc (UFPT)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $2.36B
Last updated: Nov 17, 2026 at 11:05 AM ET
UFP Technologies Inc (UFPT) Earnings: Report Dates and Results
UFP Technologies (UFPT) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, UFP Technologies reported EPS of $2.88, above the $2.63 estimate. It beat the EPS estimate in each of the last 17 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
UFPT has an expected report date of Feb 22, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 5.3% above the $2.44 reported for the quarter ended Dec 31, 2025.
UFPT Earnings Call
The latest UFPT earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, UFPT beat 35 and missed 5. Revenue for the quarter ended Sep 30, 2026 was $172.43M, up 11.6% from $154.56M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $2.88 | $2.63 | $2.57 - $2.78 | +9.51% | Beat | +20.5% | 4 | 0 up, 2 down | Nov 3, 2026 | $172.43M |
| Jun 30, 2026 | $2.92 | $2.51 | $2.46 - $2.63 | +16.33% | Beat | +16.8% | 4 | 3 up, 1 down | Aug 3, 2026 | $173.96M |
| Mar 31, 2026 | $2.48 | $2.31 | $2.18 - $2.38 | +7.36% | Beat | +0.4% | 4 | 0 up, 2 down | May 4, 2026 | $154.20M |
| Dec 31, 2025 | $2.44 | $2.20 | $2.15 - $2.30 | +10.91% | Beat | -0.8% | 4 | 1 up, 3 down | Feb 24, 2026 | $148.91M |
| Sep 30, 2025 | $2.39 | $2.17 | $2.09 - $2.28 | +10.14% | Beat | 0.0% | 4 | 0 up, 2 down | Nov 3, 2025 | $154.56M |
| Jun 30, 2025 | $2.50 | $2.25 | $2.08 - $2.33 | +11.11% | Beat | +34.4% | 4 | 4 up, 0 down | Aug 4, 2025 | $151.18M |
| Mar 31, 2025 | $2.47 | $2.01 | $1.83 - $2.11 | +22.89% | Beat | +48.8% | 4 | 0 up, 0 down | May 6, 2025 | $148.15M |
| Dec 31, 2024 | $2.46 | $2.14 | $2.10 - $2.17 | +15.22% | Beat | +62.9% | 2 | 0 up, 1 down | Feb 25, 2025 | $144.07M |
| Sep 30, 2024 | $2.39 | $1.86 | $1.71 - $1.88 | +28.49% | Beat | +57.2% | 3 | 0 up, 0 down | Nov 5, 2024 | $145.16M |
| Jun 30, 2024 | $1.86 | $1.54 | $1.50 - $1.55 | +20.78% | Beat | +18.5% | 3 | 0 up, 0 down | Jul 31, 2024 | $110.18M |
| Mar 31, 2024 | $1.66 | $1.17 | $1.05 - $1.17 | +41.88% | Beat | +5.7% | 3 | 0 up, 0 down | May 1, 2024 | $105.01M |
| Dec 31, 2023 | $1.51 | $1.14 | $1.12 - $1.15 | +32.46% | Beat | +37.3% | 2 | 0 up, 0 down | Feb 21, 2024 | $101.50M |
| Sep 30, 2023 | $1.52 | $1.49 | $1.49 - $1.49 | +2.01% | Beat | +55.1% | 1 | 0 up, 0 down | Nov 1, 2023 | $100.78M |
| Jun 30, 2023 | $1.57 | $1.42 | $1.42 - $1.42 | +10.56% | Beat | +175.4% | 2 | 0 up, 0 down | Aug 1, 2023 | $100.04M |
| Mar 31, 2023 | $1.57 | $1.12 | $0.96 - $1.12 | +40.18% | Beat | +118.1% | 2 | 0 up, 0 down | May 2, 2023 | $97.75M |
| Dec 31, 2022 | $1.10 | $0.91 | $0.90 - $0.91 | +20.88% | Beat | +161.9% | 2 | 0 up, 0 down | Mar 7, 2023 | $91.24M |
| Sep 30, 2022 | $0.98 | $0.91 | $0.91 - $0.98 | +7.69% | Beat | +92.2% | 2 | 0 up, 0 down | Nov 2, 2022 | $96.97M |
| Jun 30, 2022 | $0.57 | $0.79 | $0.69 - $0.79 | -27.85% | Miss | -8.1% | 2 | 0 up, 0 down | Aug 2, 2022 | $94.34M |
| Mar 31, 2022 | $0.72 | $0.45 | $0.45 - $0.45 | +60.00% | Beat | +30.9% | 1 | 0 up, 0 down | May 4, 2022 | $71.24M |
| Dec 31, 2021 | $0.42 | $0.41 | $0.39 - $0.42 | +2.44% | Beat | -23.6% | 2 | 0 up, 0 down | Mar 8, 2022 | $56.34M |
| Sep 30, 2021 | $0.51 | $0.59 | $0.57 - $0.61 | -13.56% | Miss | +27.5% | 2 | 0 up, 0 down | Nov 3, 2021 | $50.72M |
| Jun 30, 2021 | $0.62 | $0.52 | $0.47 - $0.57 | +19.23% | Beat | +82.4% | 2 | N/A | Aug 3, 2021 | $50.66M |
| Mar 31, 2021 | $0.55 | $0.36 | $0.33 - $0.39 | +52.78% | Beat | +5.8% | 2 | N/A | May 4, 2021 | $48.60M |
| Dec 31, 2020 | $0.55 | $0.42 | $0.41 - $0.42 | +30.95% | Beat | -28.6% | 2 | N/A | Mar 4, 2021 | $45.15M |
| Sep 30, 2020 | $0.40 | $0.32 | $0.32 - $0.32 | +25.00% | Beat | -46.7% | 1 | N/A | Nov 3, 2020 | $43.30M |
| Jun 30, 2020 | $0.34 | $0.20 | $0.20 - $0.20 | +70.00% | Beat | -45.2% | 1 | N/A | Aug 4, 2020 | $42.64M |
| Mar 31, 2020 | $0.52 | $0.54 | $0.54 - $0.54 | -3.70% | Miss | +4.0% | 1 | N/A | May 5, 2020 | $48.28M |
| Dec 31, 2019 | $0.77 | $0.60 | $0.60 - $0.60 | +28.33% | Beat | +30.5% | 1 | N/A | Mar 4, 2020 | $50.26M |
| Sep 30, 2019 | $0.75 | $0.56 | $0.56 - $0.56 | +33.93% | Beat | +33.9% | 1 | N/A | Nov 5, 2019 | $49.39M |
| Jun 30, 2019 | $0.62 | $0.56 | $0.56 - $0.56 | +10.71% | Beat | +14.8% | 1 | N/A | Aug 6, 2019 | $51.40M |
| Mar 31, 2019 | $0.50 | $0.40 | $0.40 - $0.40 | +25.00% | Beat | +108.3% | 1 | N/A | May 7, 2019 | $47.33M |
| Dec 31, 2018 | $0.59 | $0.58 | $0.58 - $0.58 | +1.72% | Beat | +59.5% | 1 | N/A | Mar 6, 2019 | $50.70M |
| Sep 30, 2018 | $0.56 | $0.55 | $0.55 - $0.55 | +1.82% | Beat | +143.5% | 1 | N/A | Nov 1, 2018 | $47.81M |
| Jun 30, 2018 | $0.54 | $0.50 | $0.50 - $0.50 | +8.00% | Beat | +45.9% | 1 | N/A | Aug 2, 2018 | $49.02M |
| Mar 31, 2018 | $0.24 | $0.16 | $0.16 - $0.16 | +50.00% | Beat | -20.0% | 1 | N/A | May 4, 2018 | $42.93M |
| Dec 31, 2017 | $0.37 | $0.23 | $0.23 - $0.23 | +60.87% | Beat | +85.0% | 1 | N/A | Mar 1, 2018 | $37.22M |
| Sep 30, 2017 | $0.23 | $0.36 | $0.36 - $0.36 | -36.11% | Miss | +4.5% | 1 | N/A | Nov 2, 2017 | $35.68M |
| Jun 30, 2017 | $0.37 | $0.36 | $0.36 - $0.36 | +2.78% | Beat | -2.6% | 1 | N/A | Aug 2, 2017 | $37.89M |
| Mar 31, 2017 | $0.30 | $0.23 | N/A | +30.43% | Beat | +100.0% | N/A | N/A | May 3, 2017 | $37.05M |
| Dec 31, 2016 | $0.20 | $0.23 | N/A | -13.04% | Miss | -13.0% | N/A | N/A | Mar 2, 2017 | $36.51M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $9.80, up 17.1% from the year before. It was $0.95 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $9.80 | +17.1% |
| Dec 31, 2024 | $8.37 | +35.7% |
| Dec 31, 2023 | $6.17 | +83.1% |
| Dec 31, 2022 | $3.37 | +60.5% |
| Dec 31, 2021 | $2.10 | +16.0% |
| Dec 31, 2020 | $1.81 | -31.4% |
| Dec 31, 2019 | $2.64 | +36.8% |
| Dec 31, 2018 | $1.93 | +52.0% |
| Dec 31, 2017 | $1.27 | +33.7% |
| Dec 31, 2016 | $0.95 | N/A |
Earnings Calls
The 7 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 2,500 words across 7 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 2,515 | 7 | |
| 2026Q2 | Jun 30, 2026 | 2,680 | 7 | |
| 2026Q1 | Mar 31, 2026 | 2,884 | 6 | |
| 2025Q4 | Dec 31, 2025 | 3,479 | 7 | |
| 2025Q3 | Sep 30, 2025 | 3,704 | 8 | |
| 2025Q2 | Jun 30, 2025 | 3,502 | 7 | |
| 2025Q1 | Mar 31, 2025 | 4,265 | 7 |
2026Q3 Earnings Call
Opening remarks
Ronald Lataille Senior Vice President, Treasurer and CFO Thank you, operator. Good morning, and thank you for joining us on our 2026 third quarter earnings conference call. With me on today's call is our CEO, Mitch Rock. Today, we will make some forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, the accuracy of which is subject to risks and uncertainties. Wherever possible, we will try to identify those forward-looking statements by using words such as believe, expect, anticipate, pursue, forecast, and similar expressions. Our forward-looking statements are based on our estimates and assumptions as of today and should not be relied upon as representing our estimates or views on any subsequent date. Please refer to the cautionary statement regarding forward-looking information and the risk factors in our most recent 10-K and 10-Qs, including disclosure of the factors that could cause results to differ materially from those expressed or implied. During this call, we will discuss non-GAAP financial measures, which include organic sales growth, adjusted gross margin, adjusted operating income, adjusted SG&A, adjusted EPS, EBITDA, and adjusted EBITDA. A reconciliation of GAAP to non-GAAP measures discussed in this call is contained in the associated press release and is available in the Investor Relations section of our website. I'll now turn the call over to Mitch.
Mitchell Rock CEO Thank you, Ron. Good morning, everyone, and thank you for joining us. Our third quarter reflects solid execution across UFP and steady progress on our long-term growth strategy. Third quarter sales were $172.4 million, up 11.6%. Organic growth was 11.1%. Gross margin increased to 29.4%, adjusted operating income grew 14.5%, and adjusted earnings per share increased to $2.88. Year-to-date, sales are up 10.3%, to $500.6 million. MedTech grew 11.7%, and our top five MedTech customers collectively also grew 11.7%. What stands out to me is how broad the growth is. MedTech sales were up 12.5% in the quarter, with demand across the portfolio. One of the real strengths of UFP is that our growth does not depend on any single customer, program, or end market. We were proud to be recognized by one of our top five customers with a supplier award for creating value through innovation and cost savings. That's exactly what we're aiming for: line up with where our customers are going long term and help them scale while taking costs out. On operations, we are continuing to make progress. We are scaling new programs in the Dominican Republic. Margins are improving in our legacy UFP operations. And at AJR, we have made significant year-over-year progress, both in the U.S. and in the Dominican Republic. That said, we're behind schedule moving AJR activity to the Dominican Republic.
Frequently Asked Questions About UFPT
When is UFP Technologies's next earnings date?
UFP Technologies's next earnings report is expected for Feb 22, 2027.
Did UFPT beat earnings estimates last quarter?
Yes. UFP Technologies reported EPS of $2.88 for the quarter ended Sep 30, 2026, above the $2.63 estimate, a 9.51% surprise.
What EPS do analysts expect from UFPT next quarter?
The consensus EPS estimate for UFP Technologies for the quarter ending Dec 31, 2026 is $2.57 from 6 analysts, with estimates from $2.42 to $2.72.
How often does UFPT beat earnings estimates?
UFP Technologies beat the EPS estimate in each of the last 17 quarters, with an average surprise of +18.14%.
UFPT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts